RISE Life Science Launches Retail Location on Main Street in Santa Monica, California
Toronto, Ontario (Newsfile Corp. - June 14, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") is pleased to announce that it has launched its first Life Bloom Organics retail location in Santa Monica, California.
The Santa Monica store sells the entire Life Bloom OrganicsTM brand hemp-based CBD product line and other branded lifestyle accessories. It will also carry RISE's KarezzaTM brand hemp-based CBD sexual wellness product line. The Company anticipates that the location will be used for events and pop-ups with partner brands and retailers, further broadening RISE's consumer reach.
"For any brand, having a retail space is a fantastic way to create a brand experience; but for a Company creating hemp-based CBD products, where there is so much education that consumers want, providing a space where people can learn, touch, taste, and experience the products in person is key," explained Ryan Rocca, President of RISE.
"California is the most important market for hemp-based CBD products. Retail is a great way to meet the consumer, and this location is a high traffic lifestyle hub: the famous heart of Dogtown, blocks from the beach, with decades of history in SoCal's surf and skate community."
The new retail store is located at 2665 Main Street, Santa Monica, CA 90405.
About RISE Life Science Corp.
RISE is currently developing and evolving medical and adult-use hemp-based formulations to create general use health and well-being products for the emerging consumer category made possible by the legalization of hemp in the United States pursuant to the Agricultural Improvement Act of 2018. The Company launched its CBD-based sexual wellness products in June 2018. The acquisition of Life Bloom Organics in July 2018 expanded RISE's portfolio of CBD products from sexual health and wellness products to include general wellness, sleep, muscle recovery, intimacy and PMS products, and provides access to Life Bloom's existing channels of distribution and production in the United States and California in particular. RISE also leverages Life Bloom's proprietary process of nanotizing CBD for increased bioavailability (without psychoactivity) in future products created under the RISE brand umbrella.
RISE's Life Bloom OrganicsTM brand and KarezzaTM brand proprietary 'Nano' hemp extract oral sprays, quick-dissolve oral tablets, and topical balms and lotions can be found at natural health food markets, chiropractic offices, specialty retailers and medical dispensaries in Southern California, as well as online at lifebloomorganics.com and karezza.love.
Cautionary Statement Regarding Forward-Looking Information
The Canadian Securities Exchange has not reviewed this news release and does not accept responsibility for the adequacy or accuracy of this news release.
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in RISE's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, continue, estimate, expect, intend, may, potential, believe, should, target, goals, projections, anticipated" and similar expressions, are forward- looking statements. Forward-looking statements may include, without limitation, statements including the Company's expectations with respect to pursuing new opportunities and its future growth and other statements of fact.
Although RISE has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: general economic conditions; pending and proposed legislative or regulatory developments including the impact of changes in laws, regulations and the enforcement thereof; reliance on funding models; operational and infrastructure risks including possible equipment failure and performance of information technology systems; intensifying competition resulting from established competitors and new entrants in the businesses in which the Company operates; insurance coverage of sufficient scope to satisfy any liability claims; fluctuations in total customers; technological change and obsolescence; loss of services of key senior management personnel; privacy laws; leverage and restrictive covenants; fluctuations in cash timing and amount of capital expenditures; tax-related risks; unpredictability and volatility of the price of the Company's securities; dilution; and future sales of the Company's securities. Further risks include operational risks of operating in the U.S.; U.S. federal regulation risks; variation in U.S. state regulations; change of U.S. cannabis laws; security risks; risks related to permits and authorizations; risks related to potential acquisitions; risks on liability, enforcement complaints etc.; banking risks; marketing, sales, manufacturing and distribution risk regarding our product growth plans; changes in laws; limited operating history; reliance on management; requirements for additional financing; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult use cannabis industry; and regulatory or political change. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events. Accordingly, readers should not place undue reliance on forward-looking statements.
For Investor inquiries, please contact:Scott Secord, Executive Chairmanscottlsecord@gmail.comT. 416.433.9259
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45604
Click on, or paste the following link into your web browser,to view the associated documents
14.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: RISE Life Science Corp.
Canada ISIN: CA76761F1053 EQS News ID: 825067 End of News DGAP News Service